Suppr超能文献

肾细胞癌患者循环细胞毒性抗肾细胞癌抗体反应

Circulating cytotoxic anti-RCC antibody responses in renal cell carcinoma patients.

作者信息

Ishibashi M, Matsuda M, Osafune M, Nakano E, Fujioka H, Takaha M, Sonoda T, Kotake T, Watanabe S

出版信息

Hinyokika Kiyo. 1983 Feb;29(2):121-9.

PMID:6677115
Abstract

The circulating anti-RCC cytotoxic antibodies of eighteen RCC patients, preoperatively, and one inoperable case were studied by 51Cr release CDC and ADCC assays, using the cultured human RCC cell line, OUR-10. Circulating cytotoxic anti-RCC antibodies were detected in eight patients as CDC antibodies. The patients with a low pathological grade had a significantly higher percentage (P less than 0.05) of positive antibody responses.

摘要

使用培养的人肾癌细胞系OUR-10,通过51Cr释放补体依赖的细胞毒性(CDC)和抗体依赖的细胞介导的细胞毒性(ADCC)试验,对18例肾癌患者术前及1例无法手术的病例的循环抗肾癌细胞毒性抗体进行了研究。在8例患者中检测到循环细胞毒性抗肾癌细胞抗体,作为CDC抗体。病理分级低的患者抗体阳性反应百分比显著更高(P小于0.05)。

相似文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验